Biocompatible copper sulfide–based nanocomposites for artery interventional chemo-photothermal therapy of orthotropic hepatocellular carcinoma
Source abstract
Abstract
Transcatheter arterial embolization has been considered as a promising targeted delivery approach for hepatocellular carcinoma (HCC). Currently, chemoembolization was the main treatment for unresectable HCC. However, the traditional chemoembolization treatment suffers from undesirable therapeutic effects and serious side-effects. In this study, the doxorubicin (DOX)-encapsulated and near-infrared (NIR)–responsible copper sulfide (CuS)–based nanotherapeutics was developed for magnetic resonance imaging (MRI)–guided chemo-photothermal therapy of HCC tumor in rats. The DOX-loaded CuS nanocomposites ([email protected]) demonstrated distinct NIR-triggered drug release behavior and high photothermal effect. In an orthotopic HCC rat model, [email protected] nanocomposites were selectively delivered to the tumor site via the intra-arterial transcatheter. The proposed [email protected] nanocomposites plus NIR laser irradiation exhibited significant tumor growth suppression performance. Moreover, the treatment progress can be monitored by MRI images. Finally, the preliminary toxicity estimate suggested the negligible side-effect of [email protected] nanocomposites during the therapeutic process. These results suggest the clinical translational potential possibility for imaging-guided arterial embolization with [email protected] nanocomposites for the treatment of HCC.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Hepatocellular Carcinoma Treatment and Prognosis · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Major causes of death among men and women in China10.1056/NEJMsa050467 ↗
2. Whole-genome sequencing analysis of 27 liver cancers
3. Recent advances in hepatocellular carcinoma therapy10.1016/j.pharmthera.2017.02.010 ↗
4. Strategies for the management of hepatocellular carcinoma10.1038/ncponc0844 ↗
5. Treatment of hepatocellular carcinoma: present and future10.1586/era.13.21 ↗
6. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival10.1053/jhep.2003.50047 ↗
7. Hyaluronic acid/doxorubicin nanoassembly-releasing microspheres for the transarterial chemoembolization of a liver tumor10.1080/10717544.2018.1480673 ↗
8. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization10.1097/01.RVI.0000195323.46152.B3 ↗
9. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics10.1016/j.jhep.2006.10.020 ↗
10. 131I-Labeled copper sulfide-loaded microspheres to treat hepatic tumors via hepatic artery embolization10.7150/thno.21491 ↗
11. Radiopaque and uniform alginate microspheres loaded with tantalum nanoparticles for real-time imaging during transcatheter arterial embolization10.7150/thno.27379 ↗
12. Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma10.1016/j.jhep.2012.07.017 ↗
13. Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma10.1038/bjc.2014.199 ↗
14. Locoregional drug delivery using image-guided intra-arterial drug eluting bead therapy10.1016/j.jconrel.2012.01.018 ↗
15. Functional electrospun fibers for local therapy of cancer10.1007/s42765-020-00053-9 ↗
16. Biodegradable Pickering emulsions of Lipiodol for liver trans-arterial chemo-embolization10.1016/j.actbio.2019.01.054 ↗
17. Reversed lipid-based nanoparticles dispersed in iodized oil for transarterial chemoembolization10.1021/acsami.9b03110 ↗
18. Facile approach to synthesize gold Nanorod@Polyacrylic acid/calcium phosphate yolk–shell nanoparticles for dual-mode imaging and pH/NIR-responsive drug delivery
19. Fe3O4@polydopamine composite theranostic superparticles employing preassembled Fe3O4 nanoparticles as the core10.1021/acsami.6b07997 ↗
20. Indocyanine green-conjugated magnetic prussian blue nanoparticles for synchronous photothermal/photodynamic tumor therapy10.1007/s40820-018-0227-z ↗
21. Dopamine-melanin colloidal nanospheres: an efficient near-infrared photothermal therapeutic agent for in vivo cancer therapy10.1002/adma.201204683 ↗
22. BSA-directed synthesis of CuS nanoparticles as a biocompatible photothermal agent for tumor ablation in vivo10.1039/C5DT01467K ↗
23. Biocompatible tumor-targeting nanocomposites based on CuS for tumor imaging and photothermal therapy10.1039/C7RA12796K ↗
24. CuS as a gatekeeper of mesoporous upconversion nanoparticles-based drug controlled release system for tumor-targeted multimodal imaging and synergetic chemo-thermotherapy10.1016/j.nano.2017.03.008 ↗
25. Magnetic semiconductor Gd-doping CuS nanoparticles as activatable nanoprobes for bimodal imaging and targeted photothermal therapy of gastric tumors10.1021/acs.nanolett.8b04179 ↗
26. Antifouling dendrimer-entrapped copper sulfide nanoparticles enable photoacoustic imaging-guided targeted combination therapy of tumors and tumor metastasis10.1021/acsami.0c21620 ↗
27. Massive intracellular remodeling of CuS nanomaterials produces nontoxic bioengineered structures with preserved photothermal potential10.1021/acsnano.1c00567 ↗
28. A review on nano-based drug delivery system for cancer chemoimmunotherapy10.1007/s40820-020-00482-6 ↗
29. FeS nanoplates as a multifunctional nano-theranostic for magnetic resonance imaging guided photothermal therapy10.1016/j.biomaterials.2014.10.052 ↗
30. Inorganic nanozyme with combined self - oxygenation/degradable capabilities for sensitized cancer immunochemotherapy10.1007/s40820-019-0305-x ↗
31. Analysis of nanoparticle delivery to tumors10.1038/natrevmats.2016.14 ↗
32. Peptide NGR modified TiO2 nanofiber substrate for circulating tumor cells capture10.1007/s42765-020-00040-0 ↗
33. Reduce the toxicity of prepared copper sulfide nanoparticles
34. Sensitive determination of caffeine by copper sulphide nanoparticles modified carbon paste electrode10.1016/j.sna.2016.07.013 ↗
35. Aptamer-modified CuS nanocrystals/graphene oxide composites for controlled release of glucosamine and chemo-photothermal therapy of tumor cells10.1016/j.matlet.2017.02.119 ↗
36. Synergistic photothermal and photodynamic therapy for effective implant-related bacterial infection elimination and biofilm disruption using Cu9S8 nanoparticles10.1021/acsbiomaterials.9b01280 ↗
37. Microscale heat transfer transduced by surface plasmon resonant gold nanoparticles10.1021/jp064341w ↗
38. NIR II-excited and pH-responsive ultrasmall nanoplatform for deep optical tissue and drug delivery penetration and effective cancer chemophototherapy10.1021/acs.molpharmaceut.0c00404 ↗
39. A multifunctional nanocrystalline CaF2: Tm, Yb@mSiO2 system for dual-triggered and optically monitored doxorubicin delivery10.1002/ppsc.201600166 ↗
40. Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers10.1016/j.jconrel.2011.11.031 ↗
41. Tumor uptake of hollow gold nanospheres after intravenous and intra-arterial injection: PET/CT study in a rabbit VX2 liver cancer model10.1007/s11307-013-0635-x ↗
42. Doxorubicin-loaded hollow gold nanospheres for dual photothermal ablation and chemoembolization therapy10.1186/s12645-020-00062-8 ↗
43. Polydopamine-based multifunctional (nano) materials for cancer therapy10.1021/acsami.7b08392 ↗
44. Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma10.1136/gut.48.1.87 ↗
45. Lipiodol transarterial chemoembolization for hepatocellular carcinoma: a systematic review of efficacy and safety data10.1002/hep.28453 ↗
46. Transcatheter arterial chemoembolization followed by immediate radiofrequency ablation for large solitary hepatocellular carcinomas10.3748/wjg.v19.i26.4192 ↗
47. Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided microwave ablation in the treatment of small hepatocellular carcinoma10.1186/s40644-020-0294-5 ↗